Literature DB >> 16958578

A pilot study of aripiprazole in children and adolescents with Tourette's disorder.

H K Yoo, J Y Kim, C Y Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16958578     DOI： 10.1089/cap.2006.16.505

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  12 in total

1.  Aripiprazole in the treatment of early-onset schizophrenia spectrum disorder: A case series in Korean children and adolescents.

Authors:  Yeni Kim; Soo-Churl Cho; Min-Sup Shin; Jae-Won Kim; Sang-Chul Choi; Boong-Nyun Kim
Journal:  Curr Ther Res Clin Exp       Date:  2009-04

2.  Treatment strategies for tics in Tourette syndrome.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

3.  Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

Authors:  Kimberly A Stigler; Jonathan T Diener; Arlene E Kohn; Lang Li; Craig A Erickson; David J Posey; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-06       Impact factor: 2.576

4.  Focus on aripiprazole: a review of its use in child and adolescent psychiatry.

Authors:  Masa'il Greenaway; Dean Elbe
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-08

Review 5.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

6.  Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.

Authors:  Gholson J Lyon; Stephanie Samar; Rahil Jummani; Scott Hirsch; Arie Spirgel; Rachel Goldman; Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-12       Impact factor: 2.576

7.  Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders.

Authors:  Hanik K Yoo; Joong-Sun Lee; Kyoung-Won Paik; Soon-Ho Choi; Sujung J Yoon; Jieun E Kim; Jin Pyo Hong
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-12-28       Impact factor: 4.785

8.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

9.  Update on the role of antipsychotics in the treatment of Tourette syndrome.

Authors:  Daniel Huys; Katja Hardenacke; Pia Poppe; Christina Bartsch; Burak Baskin; Jens Kuhn
Journal:  Neuropsychiatr Dis Treat       Date:  2012-03-12       Impact factor: 2.570

10.  Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome.

Authors:  Sarah Gerasch; Ahmad Seif Kanaan; Ewgeni Jakubovski; Kirsten R Müller-Vahl
Journal:  Front Neurosci       Date:  2016-09-12       Impact factor: 4.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.